Elicio Therapeutics
ELTX

Elicio Therapeutics (ELTX) analyst forecast and price target

Recent analyst ratings

FirmActionRatingPrice targetDate
B. Riley SecuritiesMaintainedBuy$8.00 from $27.00Sep 24, 2026
HC Wainwright & Co.MaintainedBuy$23.00Aug 18, 2026
Ladenburg ThalmannInitiated CoverageBuy$12.00Jun 18, 2026
Jones TradingDowngradedBuy → Hold—Jun 16, 2026
HC Wainwright & Co.MaintainedBuy$23.00 from $17.00Jun 15, 2026
B. Riley SecuritiesInitiated CoverageBuy$27.00Jun 10, 2026
HC Wainwright & Co.MaintainedBuy$17.00May 28, 2026
Ladenburg ThalmannInitiated CoverageBuy$20.00Apr 15, 2026
HC Wainwright & Co.MaintainedBuy$17.00 from $13.00Mar 13, 2026
Rodman & RenshawInitiated CoverageBuy$17.00Mar 10, 2026
HC Wainwright & Co.MaintainedBuy$13.00 from $10.00Jul 17, 2025
HC Wainwright & Co.MaintainedBuy$10.00Apr 2, 2025
Jones TradingInitiated CoverageBuy$9.00Oct 31, 2024
HC Wainwright & Co.MaintainedBuy$10.00Aug 23, 2024
HC Wainwright & Co.MaintainedBuy$10.00Jun 6, 2024
HC Wainwright & Co.MaintainedBuy$10.00May 22, 2024
HC Wainwright & Co.MaintainedBuy$10.00 from $11.00May 1, 2024
OppenheimerMaintainedPerform—Apr 1, 2024
HC Wainwright & Co.MaintainedBuy$11.00 from $10.00Jan 17, 2024
HC Wainwright & Co.Initiated CoverageBuy$12.00Oct 26, 2023

Frequently asked questions

  • What is the latest analyst rating on ELTX?

    On Sep 24, 2026, B. Riley Securities maintained Elicio Therapeutics at Buy with a price target of $8.00.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.